Sfoglia per Autore
Synchronous occurrence of primary cutaneous B-cell lymphoma and cutaneous Rosai-Dorfman disease in distinct lesions: A unique association
2024-01-01 Roccuzzo, Gabriele; Avallone, Gianluca; Cavallo, Francesco; Mastorino, Luca; Conti, Luca; Fava, Paolo; Tomasini, Carlo; Ribero, Simone; Quaglino, Pietro
Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and Effectiveness
2023-01-01 Mannino, Maria; Piccerillo, Alfredo; Fabbrocini, Gabriella; Quaglino, Pietro; Argenziano, Giuseppe; Dika, Emi; Ascierto, Paolo Antonio; Pellacani, Giovanni; Longo, Caterina; Fargnoli, Maria Concetta; Bianchi, Luca; Calzavara-Pinton, Piergiacomo; Zalaudek, Iris; Fava, Paolo; Scalvenzi, Massimiliano; Bocchino, Enrico; Di Stefani, Alessandro; Peris, Ketty
Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studies
2023-01-01 Roccuzzo, Gabriele; Moirano, Giovenale; Fava, Paolo; Maule, Milena; Ribero, Simone; Quaglino, Pietro
Liver metastases and immunotherapy: A barrier to response for metastatic melanoma
2023-01-01 Marco Rubatto; Nicole Macagno; Ginevra Pastorin; Paolo Fava; Luca Ceroni; Simone Ribero; Pietro Quaglino
Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience
2023-01-01 Rubatto, Marco; Picciotto, Franco; Moirano, Giovenale; Fruttero, Enrico; Caliendo, Virginia; Borriello, Silvia; Sciamarrelli, Nadia; Fava, Paolo; Senetta, Rebecca; Lesca, Adriana; Sapino, Anna; Deandreis, Désirée; Ribero, Simone; Quaglino, Pietro
Mycosis fungoides and Sézary syndrome following dupilumab treatment: experience of two Italian tertiary care centres
2023-01-01 Buffon, Stefano; Alberti Violetti, Silvia; Avallone, Gianluca; Venegoni, Luigia; Marzano, Angelo V; Mastorino, Luca; Fava, Paolo; Ribero, Simone; Quaglino, Pietro; Ortoncelli, Michela; Ferrucci, Silvia M
Dramatic response of face desmoplastic melanoma after two doses of immunotherapy
2023-01-01 Rubatto, Marco; Gelato, Federica; Broganelli, Paolo; Fava, Paolo; Senetta, Rebecca; Avallone, Gianluca; Mastorino, Luca; Grandinetti, Damiano; Ribero, Simone; Quaglino, Pietro
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals
2022-01-01 Avallone, Gianluca; Maronese, Carlo Alberto; Conforti, Claudio; Fava, Paolo; Gargiulo, Luigi; Marzano, Angelo Valerio; Massone, Cesare; Mastorino, Luca; Paradisi, Andrea; Pileri, Alessandro; Quaglino, Pietro; Rizzo, Nathalie; Ribero, Simone; Roccuzzo, Gabriele; Tavoletti, Gianluca; Vignoli, Carlo Alberto; Zalaudek, Iris; Berti, Emilio; Alberti-Violetti, Silvia
Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course
2022-01-01 Macagno, N; Mastorino, L; Rubatto, M; Avallone, G; Merli, M; Agostini, A; Fava, P; Ribero, S; Quaglino, P
Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management
2022-01-01 Fava P.; Roccuzzo G.; Alberti-Violetti S.; Grandi V.; Pileri A.; Pimpinelli N.; Berti E.; Quaglino P.
Infections in Sézary syndrome: A retrospective cohort study of 113 patients
2022-01-01 Cariti C.; Quaglino P.; Lupia T.; Novelli M.; Marra E.; Fava P.; Caliendo V.; Tonella L.; De Rosa F.G.; Fierro M.T.; Ribero S.
Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin
2022-01-01 Roccuzzo, Gabriele; Fava, Paolo; Avallone, Gianluca; Aquino, Carola; Boskovic, Sara; Macagno, Nicole; Ribero, Simone; Quaglino, Pietro
Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System
2022-01-01 G. Roccuzzo, S. Giordano, G. Avallone, M. Rubatto, S. Canonico, A. Funaro, E. Ortolan, R. Senetta, P. Fava, M.T. Fierro, S. Ribero, P. Quaglino
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome?
2022-01-01 Cavallo, Francesco; Roccuzzo, Gabriele; Avallone, Gianluca; Conforti, Claudio; Zalaudek, Iris; Giordano, Silvia; Rubatto, Marco; Fava, Paolo; Ribero, Simone; Quaglino, Pietro
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study
2022-01-01 Gullo G.; Rubatto M.; Fava P.; Brizio M.; Tonella L.; Ribero S.; Medri M.; Avallone G.; Mastorino L.; Fierro M.T.; Stanganelli I.; Quaglino P.
CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study
2022-01-01 Quaglino P.; Novelli M.; Fava P.; Ortolan E.; Astrua C.; Tonella L.; Tomasini C.F.; Senetta R.; Ribero S.; Ponti R.; Fierro M.T.; Funaro A.
Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association
2022-01-01 Roccuzzo G.; Cavallo F.; Avallone G.; Fava P.; Conti L.; Ribero S.; Fierro M.T.; Quaglino P.
Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice
2022-01-01 Roccuzzo, Gabriele; Mastorino, Luca; Gallo, Giuseppe; Fava, Paolo; Ribero, Simone; Quaglino, Pietro
Perspectives of immunotherapy in non-melanoma skin cancers
2021-01-01 Rubatto M.; Fava P.; Avallone G.; Agostini A.; Mastorino L.; Merli M.; Ribero S.; Quaglino P.
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome
2021-01-01 Quaglino P.; Fava P.; Pileri A.; Grandi V.; Sanlorenzo M.; Panasiti V.; Guglielmo A.; Alberti-Violetti S.; Novelli M.; Astrua C.; Rubatto M.; Tonella L.; Berti E.; Pimpinelli N.; Osella Abate S.; Fierro M.T.; Vermeer M.; Scarisbrick J.J.; Ribero S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Synchronous occurrence of primary cutaneous B-cell lymphoma and cutaneous Rosai-Dorfman disease in distinct lesions: A unique association | 2024 | Roccuzzo, Gabriele; Avallone, Gianluca; Cavallo, Francesco; Mastorino, Luca; Conti, Luca; Fava, Paolo; Tomasini, Carlo; Ribero, Simone; Quaglino, Pietro | |
| Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and Effectiveness | 2023 | Mannino, Maria; Piccerillo, Alfredo; Fabbrocini, Gabriella; Quaglino, Pietro; Argenziano, Giuseppe; Dika, Emi; Ascierto, Paolo Antonio; Pellacani, Giovanni; Longo, Caterina; Fargnoli, Maria Concetta; Bianchi, Luca; Calzavara-Pinton, Piergiacomo; Zalaudek, Iris; Fava, Paolo; Scalvenzi, Massimiliano; Bocchino, Enrico; Di Stefani, Alessandro; Peris, Ketty | |
| Obesity and immune-checkpoint inhibitors in advanced melanoma: A meta-analysis of survival outcomes from clinical studies | 2023 | Roccuzzo, Gabriele; Moirano, Giovenale; Fava, Paolo; Maule, Milena; Ribero, Simone; Quaglino, Pietro | |
| Liver metastases and immunotherapy: A barrier to response for metastatic melanoma | 2023 | Marco Rubatto; Nicole Macagno; Ginevra Pastorin; Paolo Fava; Luca Ceroni; Simone Ribero; Pietro Quaglino | |
| Sentinel Lymph Node Biopsy in Malignant Melanoma of the Head and Neck: A Single Center Experience | 2023 | Rubatto, Marco; Picciotto, Franco; Moirano, Giovenale; Fruttero, Enrico; Caliendo, Virginia; Borriello, Silvia; Sciamarrelli, Nadia; Fava, Paolo; Senetta, Rebecca; Lesca, Adriana; Sapino, Anna; Deandreis, Désirée; Ribero, Simone; Quaglino, Pietro | |
| Mycosis fungoides and Sézary syndrome following dupilumab treatment: experience of two Italian tertiary care centres | 2023 | Buffon, Stefano; Alberti Violetti, Silvia; Avallone, Gianluca; Venegoni, Luigia; Marzano, Angelo V; Mastorino, Luca; Fava, Paolo; Ribero, Simone; Quaglino, Pietro; Ortoncelli, Michela; Ferrucci, Silvia M | |
| Dramatic response of face desmoplastic melanoma after two doses of immunotherapy | 2023 | Rubatto, Marco; Gelato, Federica; Broganelli, Paolo; Fava, Paolo; Senetta, Rebecca; Avallone, Gianluca; Mastorino, Luca; Grandinetti, Damiano; Ribero, Simone; Quaglino, Pietro | |
| Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals | 2022 | Avallone, Gianluca; Maronese, Carlo Alberto; Conforti, Claudio; Fava, Paolo; Gargiulo, Luigi; Marzano, Angelo Valerio; Massone, Cesare; Mastorino, Luca; Paradisi, Andrea; Pileri, Alessandro; Quaglino, Pietro; Rizzo, Nathalie; Ribero, Simone; Roccuzzo, Gabriele; Tavoletti, Gianluca; Vignoli, Carlo Alberto; Zalaudek, Iris; Berti, Emilio; Alberti-Violetti, Silvia | |
| Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single-centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course | 2022 | Macagno, N; Mastorino, L; Rubatto, M; Avallone, G; Merli, M; Agostini, A; Fava, P; Ribero, S; Quaglino, P | |
| Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management | 2022 | Fava P.; Roccuzzo G.; Alberti-Violetti S.; Grandi V.; Pileri A.; Pimpinelli N.; Berti E.; Quaglino P. | |
| Infections in Sézary syndrome: A retrospective cohort study of 113 patients | 2022 | Cariti C.; Quaglino P.; Lupia T.; Novelli M.; Marra E.; Fava P.; Caliendo V.; Tonella L.; De Rosa F.G.; Fierro M.T.; Ribero S. | |
| Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin | 2022 | Roccuzzo, Gabriele; Fava, Paolo; Avallone, Gianluca; Aquino, Carola; Boskovic, Sara; Macagno, Nicole; Ribero, Simone; Quaglino, Pietro | |
| Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System | 2022 | G. Roccuzzo, S. Giordano, G. Avallone, M. Rubatto, S. Canonico, A. Funaro, E. Ortolan, R. Senetta, P. Fava, M.T. Fierro, S. Ribero, P. Quaglino | |
| Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? | 2022 | Cavallo, Francesco; Roccuzzo, Gabriele; Avallone, Gianluca; Conforti, Claudio; Zalaudek, Iris; Giordano, Silvia; Rubatto, Marco; Fava, Paolo; Ribero, Simone; Quaglino, Pietro | |
| Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study | 2022 | Gullo G.; Rubatto M.; Fava P.; Brizio M.; Tonella L.; Ribero S.; Medri M.; Avallone G.; Mastorino L.; Fierro M.T.; Stanganelli I.; Quaglino P. | |
| CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study | 2022 | Quaglino P.; Novelli M.; Fava P.; Ortolan E.; Astrua C.; Tonella L.; Tomasini C.F.; Senetta R.; Ribero S.; Ponti R.; Fierro M.T.; Funaro A. | |
| Guttate psoriasis in a patient with mycosis fungoides in treatment with Brentuximab vedotin: An unreported association | 2022 | Roccuzzo G.; Cavallo F.; Avallone G.; Fava P.; Conti L.; Ribero S.; Fierro M.T.; Quaglino P. | |
| Folliculotropic Mycosis Fungoides: Current Guidance and Experience from Clinical Practice | 2022 | Roccuzzo, Gabriele; Mastorino, Luca; Gallo, Giuseppe; Fava, Paolo; Ribero, Simone; Quaglino, Pietro | |
| Perspectives of immunotherapy in non-melanoma skin cancers | 2021 | Rubatto M.; Fava P.; Avallone G.; Agostini A.; Mastorino L.; Merli M.; Ribero S.; Quaglino P. | |
| Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome | 2021 | Quaglino P.; Fava P.; Pileri A.; Grandi V.; Sanlorenzo M.; Panasiti V.; Guglielmo A.; Alberti-Violetti S.; Novelli M.; Astrua C.; Rubatto M.; Tonella L.; Berti E.; Pimpinelli N.; Osella Abate S.; Fierro M.T.; Vermeer M.; Scarisbrick J.J.; Ribero S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile